We also reported that a significantly higher serum FGF23 level and a significantly lower serum phosphate level were associated with TIR/O patients compared with XLH patients, which probably cause the huge differences of skeletal status between these two hypophosphatemic disorders. This evidence concerns the gene FGF23 and X-linked hypophosphatemia.